| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |